Display options
Share it on

Int J Womens Dermatol. 2021 Aug 26; doi: 10.1016/j.ijwd.2021.08.008. Epub 2021 Aug 26.

DERMATOLOGY IN A MULTIDISCIPLINARY APPROACH WITH INFECTIOUS DISEASE AND OBSTETRIC MEDICINE AGAINST COVID-19.

International journal of women's dermatology

Rachel K Lim, Saisanjana Kalagara, Kenneth K Chen, Eleftherios Mylonakis, George Kroumpouzos

Affiliations

  1. Alpert Medical School at Brown University, Providence, RI, USA.
  2. Division of Infectious Diseases, Alpert Medical School at Brown University, Providence, RI, USA.
  3. Division of Obstetric and Consultative Medicine, Alpert Medical School at Brown University, Providence, RI, USA.
  4. Department of Dermatology, Alpert Medical School at Brown University, Providence, RI, USA.
  5. Department of Dermatology, Medical School of Jundiaí, São Paulo, Brazil.
  6. GK Dermatology, PC, S Weymouth, MA, USA.

PMID: 34462725 PMCID: PMC8388141 DOI: 10.1016/j.ijwd.2021.08.008

Abstract

Coronavirus disease 2019 (COVID-19) care requires a team approach, and dermatologists may collaborate with other specialties, especially infectious disease (ID) medicine and obstetrics and gynecology (ObGyn) at every stage of the infection process. A broad spectrum of cutaneous manifestations may occur early in COVID-19, making appropriate dermatologic identification critical for early diagnosis. There is prognostic value in appropriately identifying different types of COVID-19-associated skin manifestations which have been linked to disease severity. Such observations emanated from dermatology research, especially large series and international registry of cutaneous manifestations relating to COVID-19, and impact COVID-19 care provided by most healthcare providers. Also, research based on international registry of skin reactions from COVID-19 vaccines is having an impact across disciplines. An increased risk for severe illness from COVID-19 is encountered in pregnancy, and dermatologists' role is to urge ObGyn and other clinicians to monitor and educate pregnant patients about the potential for some eruptions being a manifestation of COVID-19. ID and ObGyn experts indicate that teledermatology enhanced the interaction among healthcare providers and improved COVID-19 care. Over 40% of all dermatology consults at a tertiary care hospital were done via teledermatology. Future collaborative research involving dermatology and specialties such as ID and ObGyn could help delineate guidelines for dermatology consult in COVID-19 patients and determine cases appropriate for teledermatology.

© 2021 Published by Elsevier Inc. on behalf of Women's Dermatologic Society.

Keywords: COVID-19; dermatology; eruption; infectious disease; obstetric medicine; pregnancy; skin; vaccine

Conflict of interest statement

The authors have no conflicts of interest. Eleftherios Mylonakis was involved in clinical trials on COVID-19. These trials were supported by Regeneron, NIH, and SciClone Pharmaceuticals, Inc. All fund

References

  1. J Am Acad Dermatol. 2020 Jul;83(1):e69-e71 - PubMed
  2. J Eur Acad Dermatol Venereol. 2020 Jul;34(7):e291-e293 - PubMed
  3. Front Med (Lausanne). 2021 Feb 16;8:634208 - PubMed
  4. FASEB J. 2019 Feb;33(2):2599-2609 - PubMed
  5. Int J Antimicrob Agents. 2020 Aug;56(2):106024 - PubMed
  6. J Eur Acad Dermatol Venereol. 2020 May;34(5):e210-e211 - PubMed
  7. Clin Dermatol. 2021 May-Jun;39(3):451-456 - PubMed
  8. Am J Clin Dermatol. 2020 Oct;21(5):627-639 - PubMed
  9. Clin Dermatol. 2016 May-Jun;34(3):320-6 - PubMed
  10. Healthcare (Basel). 2020 Oct 01;8(4): - PubMed
  11. J Eur Acad Dermatol Venereol. 2020 Oct;34(10):e536-e537 - PubMed
  12. Br J Dermatol. 2020 Oct;183(4):784-785 - PubMed
  13. Br J Dermatol. 2020 Jul;183(1):71-77 - PubMed
  14. Br J Dermatol. 2021 May;184(5):880-887 - PubMed
  15. Dermatopathology (Basel). 2020 Jun 30;7(1):3-16 - PubMed
  16. Am J Obstet Gynecol. 2020 Jun;222(6):521-531 - PubMed
  17. Lancet Infect Dis. 2021 Mar;21(3):313-314 - PubMed
  18. Clin Dermatol. 2021 May-Jun;39(3):479-487 - PubMed
  19. J Am Acad Dermatol. 2021 Jul;85(1):46-55 - PubMed
  20. Dermatol Ther. 2020 Nov;33(6):e13883 - PubMed
  21. BMJ Case Rep. 2021 Jan 6;14(1): - PubMed
  22. J Eur Acad Dermatol Venereol. 2020 May;34(5):e212-e213 - PubMed
  23. Eur J Endocrinol. 2021 May;184(5):637-645 - PubMed
  24. Dermatol Ther. 2020 Jul;33(4):e13562 - PubMed
  25. Front Immunol. 2020 Jul 07;11:1672 - PubMed
  26. J Eur Acad Dermatol Venereol. 2020 Sep;34(9):e451-e452 - PubMed
  27. JAMA Dermatol. 2020 Sep 1;156(9):998-1003 - PubMed
  28. J Eur Acad Dermatol Venereol. 2021 Jun;35(6):e359-e361 - PubMed
  29. J Cosmet Dermatol. 2020 Jul;19(7):1545-1547 - PubMed
  30. Dermatol Ther. 2020 Nov;33(6):e14170 - PubMed
  31. J Eur Acad Dermatol Venereol. 2020 Nov;34(11):2505-2510 - PubMed
  32. J Eur Acad Dermatol Venereol. 2021 Jan;35(1):e13-e15 - PubMed
  33. Cleve Clin J Med. 2020 May 14;: - PubMed
  34. Dermatol Ther. 2020 Jul;33(4):e13773 - PubMed
  35. J Leukoc Biol. 2021 Jan;109(1):55-66 - PubMed
  36. J Eur Acad Dermatol Venereol. 2020 Oct;34(10):e559-e561 - PubMed
  37. J Invest Dermatol. 2021 Jan;141(1):206-209.e1 - PubMed
  38. Dermatol Ther. 2020 Jul;33(4):e13758 - PubMed
  39. J Am Acad Dermatol. 2020 May;82(5):e173-e175 - PubMed
  40. J Leukoc Biol. 2006 Jul;80(1):117-24 - PubMed
  41. Br J Dermatol. 2021 Aug;185(2):445-447 - PubMed
  42. Dermatol Ther. 2020 Sep;33(5):e13521 - PubMed
  43. Am J Obstet Gynecol. 2011 Jul;205(1):10-8 - PubMed
  44. Int J Dermatol. 2020 Oct;59(10):1278-1279 - PubMed
  45. J Am Acad Dermatol. 2020 Oct;83(4):1118-1129 - PubMed
  46. J Am Acad Dermatol. 2018 Oct;79(4):617-633 - PubMed
  47. Dermatol Ther. 2020 Nov;33(6):e14117 - PubMed
  48. Am J Case Rep. 2021 Mar 20;22:e929489 - PubMed
  49. Int J Womens Dermatol. 2021 Mar;7(2):217-223 - PubMed
  50. J Eur Acad Dermatol Venereol. 2020 Oct;34(10):e541-e542 - PubMed
  51. Dermatol Ther. 2020 Nov;33(6):e14290 - PubMed
  52. Am J Perinatol. 2020 Jun;37(8):773-779 - PubMed
  53. J Am Acad Dermatol. 2021 Jan;84(1):156-158 - PubMed
  54. Dermatol Ther. 2020 Sep;33(5):e13420 - PubMed
  55. Nature. 2020 Dec;588(7837):315-320 - PubMed
  56. Int J Dermatol. 2020 Nov;59(11):1358-1370 - PubMed
  57. Am J Obstet Gynecol. 2021 Apr;224(4):389.e1-389.e9 - PubMed
  58. Transl Res. 2020 Jun;220:1-13 - PubMed
  59. Cutis. 2020 Dec;106(6):318-320 - PubMed
  60. J Am Acad Dermatol. 2020 Aug;83(2):486-492 - PubMed
  61. JAAD Int. 2021 Mar;2:119-133 - PubMed
  62. Rheumatology (Oxford). 2021 Jan 5;60(1):479-480 - PubMed
  63. Int J Mol Sci. 2020 Apr 22;21(8): - PubMed
  64. Cell. 2020 Apr 16;181(2):271-280.e8 - PubMed
  65. Int J Dermatol. 2020 Jul;59(7):874-875 - PubMed
  66. Biomed Res Int. 2020 Jul 5;2020:1236520 - PubMed
  67. J Cutan Med Surg. 2021 Mar-Apr;25(2):169-176 - PubMed
  68. Clin Case Rep. 2020 Dec 18;9(2):830-834 - PubMed
  69. JAMA Pediatr. 2021 Aug 1;175(8):817-826 - PubMed
  70. Dermatol Ther. 2020 Nov;33(6):e14161 - PubMed
  71. Int J Dermatol. 2021 Jul;60(7):e267-e268 - PubMed
  72. Dermatol Ther. 2020 Jul;33(4):e13523 - PubMed
  73. J Am Acad Dermatol. 2021 May;84(5):1356-1363 - PubMed
  74. BMJ Case Rep. 2021 Apr 7;14(4): - PubMed
  75. Dermatol Ther. 2021 Mar;34(2):e14753 - PubMed

Publication Types